Disease X

From WikiMD's WELLNESSPEDIA

Disease X is a hypothetical pathogen, representing a global pandemic threat as identified by the World Health Organization (WHO). The term was coined by the WHO in 2018 to represent the potential for an unknown international epidemic.

Overview[edit]

Disease X represents the knowledge that a serious international epidemic could be caused by a pathogen currently unknown to cause human disease. It is a placeholder for a contagious disease that could emerge in the future, but is not yet known to exist. The concept was included in the WHO's 2018 R&D Blueprint, a watchlist for diseases that pose a high risk of causing a public health emergency but lack effective treatments or vaccines.

Potential Origins[edit]

Disease X could emerge from a variety of sources. It could be a completely new disease, such as HIV/AIDS was in the 20th century, or it could be a known disease that has mutated to become more deadly or contagious, such as influenza. It could also be a disease that has jumped from animals to humans, known as a zoonotic disease, similar to Ebola or SARS.

Preparedness and Response[edit]

The inclusion of Disease X in the WHO's R&D Blueprint is intended to encourage research and development in new technologies and platforms that can be used to create diagnostics, vaccines, and treatments that can be rapidly deployed against the unknown disease. The WHO also encourages countries to strengthen their public health infrastructure and surveillance systems to detect and respond to Disease X if and when it emerges.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.